Investment Summary

Alta Partners and TPG Invest In Aerie

On October 12, 2005, venture capital firm Alta Partners and private equity firm TPG invested in life science company Aerie

Investment Highlights
  • This is Alta Partners’ 25th and TPG’s 9th transaction in the Life Science sector.
  • This is Alta Partners’ 23rd and TPG’s 49th transaction in the United States.
  • This is Alta Partners’ 2nd and TPG’s 3rd transaction in North Carolina.
Investment Fate
  • Aerie went public in 2013.
  • Aerie was sold to a strategic buyer in 2022 for 770M USD.

Investment Summary

Date 2005-10-12
Target Aerie
Sector Life Science
Investor(s) Alta Partners
TPG
Deal Type Venture

Target

Aerie

Durham, North Carolina, United States
Aerie is a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD). Aerie was founded in 2005 and is based in Durham, North Carolina.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

Alta Partners

Jackson, Wyoming, United States

Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1996
PE ASSETS 2.6B USD
Size Large
Type Sector Focused
DESCRIPTION

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.


DEAL STATS #
Overall 29 of 59
Sector: Life Science M&A 25 of 50
Type: Venture M&A Deals 23 of 48
State: North Carolina M&A 2 of 3
Country: United States M&A 23 of 50
Year: 2005 M&A 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-09-14 Cellective Therapeutics

Gaithersburg, Maryland, United States

Cellective Therapeutics was a biopharmaceutical company focused on developing monoclonal antibodies for the treatment of oncology and autoimmune diseases such as B-cell lymphoma, Crohn?s disease and rheumatoid arthritis. The Company was founded in 2003 by Dr. Tom Tedder, Chairman of the Department of Immunology at Duke University, and based on technology licensed from Duke University and the Dana Farber Cancer Institute. Cellective was acquired by MedImmune in September of 2005.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-17 Celetronix USA

Simi Valley, California, United States

Celetronix USA, Inc. provides electronic design and prototyping services through manufacturing and supply chain management.

Sell -
Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 67 of 453
Sector: Life Science M&A 9 of 46
Type: Venture M&A Deals 18 of 93
State: North Carolina M&A 3 of 11
Country: United States M&A 49 of 299
Year: 2005 M&A 13 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-03 Texas Genco Holdings

Houston, Texas, United States

Texas Genco Holdings, Inc., based in Houston, Texas, is an electric power generating company with over 14,000 megawatts of generation capacity. It sells electric generation capacity, energy and ancillary services in one of the nation's largest power markets, the Electric Reliability Council of Texas (ERCOT). Texas Genco has one of the most diversified generation portfolios in Texas, using natural gas, oil, coal, lignite, and uranium fuels. The company owns and operates 60 generating units at 11 electric power-generating facilities and owns a 30.8 percent interest in a nuclear generating plant.

Sell $5.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-20 Smart Modular Technologies

Newark, California, United States

Smart Modular Technologies is a developer and manufacturer of DRAM and Flash-based modules and subsystems for computing, communications, embedded, and defense applications. Smart Modular Technologies was founded in 1988 and is based in Newark, California.

Sell -